FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

2843511000001105: Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25642101000001119 Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38105801000001117 Relifex 500mg dispersible tablets (Meda Pharmaceuticals Ltd) 60 tablet 6 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Is a Nabumetone 500mg dispersible tablets 60 tablet true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Is pack of Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has active ingredient Nabumetone false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has AMP Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has specific active ingredient Nabumetone true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start